Results 131 to 140 of about 20,435 (278)

Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study

open access: yesInternational Journal of COPD, 2017
Keisaku Fujimoto,1 Haruna Yamazaki,2 Midori Ura,2 Yoshiaki Kitaguchi3 1Department of Clinical Laboratory Sciences, School of Health Sciences, 2Department of Biomedical Laboratory Science, Graduate School of Medicine, 3First Department of Internal ...
Fujimoto K   +3 more
doaj  

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

open access: yesInternational Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Duración del efecto broncodilatador de la furosemida inhalada por pacientes asmáticos

open access: yesRevista Cubana de Medicina, 2002
Se diseñó un estudio para evaluar si después de 4 h de administrada la furosemida inhalada por pacientes asmáticos con algún grado de obstrucción bronquial, persistía el efecto broncodilatador y se comparó con el salbutamol. Se estudiaron 40 pacientes de
Juan Carlos Rodríguez Vázquez   +3 more
doaj  

Enhanced Donor Lung Viability During Prolonged <i>Ex Vivo</i> Lung Perfusion Using ECMO Technology. [PDF]

open access: yesTranspl Int
Faizov L   +8 more
europepmc   +1 more source

Testing Bronchodilator Responsiveness with Glycopyrronium after Salbutamol: Appraisal of an Independent Class Specific Effect of Antimuscarinic Agent

open access: hybrid
Rantu Paul   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy